Maternal sepsis: Epidemiology, etiology and outcome

Current Opinion in Infectious Diseases

Volumn 23, Issue 3, 2010, Pages 249-254

  Van Dillen, Jeroen ^a   Zwart, Joost ^b   Schutte, Joke ^a   Van Roosmalen, Jos ^b,c  

^a Reinier de Graaf Gasthuis ^*  (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Genital tract sepsis; Maternal mortality; Pregnancy; Severe maternal morbidity

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC PROPHYLAXIS; CESAREAN SECTION; DEVELOPED COUNTRY; DEVELOPING COUNTRY; FEVER; HUMAN; INFECTION PREVENTION; INFECTION RISK; MATERNAL DISEASE; MORBIDITY; MORTALITY; OUTCOMES RESEARCH; PUERPERAL INFECTION; PUERPERIUM; REVIEW; SEPSIS; STREPTOCOCCUS GROUP A;

FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PUERPERAL INFECTION; SEPSIS; TREATMENT OUTCOME;

EID: 77951621110     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0b013e328339257c     Document Type: Review

References (38)

1. Fernandez-Perez ER, Salman S, Pendem S, Farmer JC. Sepsis during pregnancy. Crit Care Med 2005; 33:s286-s293.
2. Loudon I. Death in childbirth: an international study of maternal care and maternal mortality. Oxford: Clarendon Press; 1992. pp. 1800-1950.
3. Khan KS, Wojdyla D, Say L, et al. WHO analysis of causes of maternal death: a systematic review. Lancet 2006; 367:1066-1074.
4. Black V, Brooke S, Chersich MF. Effect of human immunodeficiency virus treatment on maternal mortality at a tertiary center in South Africa: a five year audit. Obstet Gynecol 2009; 114:292-299.
5. Van Dillen J, Meguid T, van Roosmalen J. Maternal mortality audit in a hospital in Northern Namibia: the impact of HIV/AIDS. Acta Obstet Gynecol Scand 2006; 85:499-500.
6. Kramer HMC, Schutte JM, Zwart JJ, et al. Maternal mortality and severe morbidity from sepsis in the Netherlands. Acta Obstet Gynecol 2009; 88:647-653.
7. Bone RC, Balk RA, Cerra FB, et al. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapy in sepsis. Crit Care Med 1992; 20:864-874.
8. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31:1250-1256.
9. Maharaj D. Puerperal pyrexia: a review. Part I. Obstet Gynecol Surv 2007; 62:393-399.
10. Ronsmans C, Graham WJ. Maternal mortality: who, when, where, and why. Lancet 2006; 368:1189-1200.
11. Schutte JM, Steegers EAP, Schuitemaker NWE, et al. Rise in maternal mortality in the Netherlands. BJOG 2009 [Epub ahead of print].
12. Zwart JJ, Dupuis JRO, Richters A, et al. Obstetric intensive care unit admission: a 2-year nationwide population based cohort study. Intensive Care Med 2010; 36:256-263.
13. Zhang WH, Alexander S, Bouvier-Colle HM, Macfarlane A, the MOMS-B Group. Incidence of severe preeclampsia, postpartum haemorrhage and sepsis as a surrogate marker for severe maternal morbidity in a European population-based study: the MOMS-B survey. BJOG 2005; 112:89-96.
14. Paruk F. Infections in obstetrical critical care. Best Prac Res Clin Obstet Gynaecol 2008; 22:865-883.
15. Funk DJ, Parrillo JE, Kumar A. Sepsis and septic shock: a history. Crit Care Clin 2009; 25:83-101.
16. Byrne JLB, Aagaard-Tillery KM, Johnson JL, et al. Group A streptococcal puerperal sepsis: initial characterization of virulence factors in association with clinical parameters. J Reprod Immun 2009; 82:74-83.
17. Burke Sosa ME. Streptococcal A infection: reemerging and virulent. J Perinat Neonat Nurs 2009; 23:141-147.
18. Schuitemaker N, van Roosmalen J, Dekker G, et al. Increased maternal mortality in The Netherlands from Group A streptococcal infections. Eur J Obstet Gynecol Reprod Biol 1998; 79:57-62.
19. Chuang I, Van Beneden C, Beall B, Schuchat A. Population-based surveillance for postpartum invasive group a streptococcus infections, 1995-2000. Clin Infect Dis 2002; 35:665-670.
20. Vlaminckx BJ, Schuren FH, Montijn RC, et al. Dynamics in prophage content of invasive and noninvasive M1 and M28 Streptococcus pyogenes isolates in The Netherlands from 1959 to 1996. Infect Immun 2007; 75:3673-3679.
21. Smaill FM, Gyte GML. Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section. Cochrane Database Syst Rev 2010:CD007482. doi: 10.1002/14651858.CD007482.pub2.
22. Dolea C, Stein C. Global burden of maternal sepsis in the year 2000. Evidence and information for policy. Geneva: World Health Organization; 2003.
23. Dijkman A, Huisman CMA, Smit M, et al. Cardiac arrest in pregnancy: increasing use of perimortem caesarean section due to emergency skills training? BJOG 2010; 117:282-287.
24. Levy MM, Dellinger RP, Townsend SR, et al. The Surviving Sepsis Campaign:results of an international guideline-based performance improvement program targeting severe sepsis. Intensive Care Med 2010; 36:222-231.
25. Zafar S, Hafeez A, Qureshi F, et al. Structured training in the management of emergencies in mothers, babies and children in poorly resourced health system: logbooks to document skill use. Resuscitation 2009; 80:449-452.
26. Annane D, Bellisant E, Bollaert PD, et al. Corticosteroids in the treatment of severe sepsis and septic shock in adults, a systematic review. JAMA 2009; 301:2362-2375.
27. Sligl WI, Milner DA, Sundar S, et al. Safety and efficacy of corticosteroids for the treatment of septic shock: a systematic review and meta-analysis. Clin Infect Dis 2009; 49:93-101.
28. Maharaj D. Puerperal pyrexia: a review. Part II. Obstet Gynecol Surv 2007; 62:400-406.
29. Antibiotics for prelabour rupture of membranes at or near term. Cochrane Database Syst Revs 2002:CD001807. doi: 10.1002/14651858. CD001807.
30. Thinkhamrop J, Hofmeyr GJ, Adetoro O, Lumbiganon P. Prophylactic antibiotic administration in pregnancy to prevent infectious morbidity and mortality. Cochrane Database Syst Rev 2002:CD002250. doi: 10.1002/14651 858.CD002250.
31. Aboud S, Msamanga G, Read JS, et al. Effect of prenatal and perinatal antibiotics on maternal health in Malawi, Tanzania and Zambia. Int J Gynecol Obstet 2009; 107:202-207.
32. Kenyon S, Pike K, Jones DR, et al. Childhood outcomes after prescription of antibiotics to pregnant women with spontaneous preterm labour: 7-year follow-up of the ORACLE II trial. Lancet 2008; 372:131 9-1327.
33. Tsu VD, Coffey PS. New and underutilised technologies to reduce maternal mortality and morbidity: what progress have we made since Bellagio 2003? BJOG 2009; 116:247-256.
34. Saleem S, Reza T, McClure EM, et al. Chlorhexidine vaginal and neonatal wipes in home births in Pakistan: a randomized controlled trial. Obstet Gynecol 2007; 110:977-985.
35. Goldenberg RL, McClure EM, Saleem S, et al. Use of vaginally administered chlorhexidine during labor to improve pregnancy outcomes. Obstet Gynecol 2006; 107:1139-1146.
36. McClure EM, Goldenberg RL, Brandes N, et al. The use of chlorhexidine to reduce maternal and neonatal mortality and morbidity in low-resource settings. Int J Gynaecol Obstet 2007; 97:89-94.
37. Sickbert-Bennett EE, Weber DJ, Gergen-Teague MF, et al. Comparative efficacy of hand hygiene agents in the reduction of bacteria and viruses. Am J Infect Control 2005; 33:67-77.
38. Paget C, Lewycka S, Colbourn T, et al. Estimation of potential effects of improved community-based drug provision, to augment health-facility strength ening, on maternal mortality due to postpartum haemorrhage and sepsis insub-Saharan Africa: an equity-effectiveness model. Lancet 2009; 374:1441-1448.